Sarah Marriott - Profile and Investment Details

Investor Profile

Sarah Marriott is a Private Equity Firm, Venture Capital based in Napa, California, United States with a diverse investment portfolio that includes companies such as Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals, Peloton Therapeutics, Ardelyx, Atara Biotherapeutics, Nabriva Therapeutics, Silverback Therapeutics, Metacrine, Prevail Therapeutics, Nuvation Bio, Editas Medicine, Relay Therapeutics, Aktis Oncology, Freenome, Scorpion Therapeutics, Avidity Biosciences, Alpine Immune Sciences, Naurex, Dicerna Pharmaceuticals, Flex Pharma, Morphic Therapeutic, ElevateBio, Surface Oncology, Collegium Pharmaceutical, Affinivax, Codiak Biosciences, Neogene Therapeutics, UNITY Biotechnology, Intellia Therapeutics, Ashvattha Therapeutics, Pieris Pharmaceuticals, Atreca, AlloVir, ORIC Pharmaceuticals, Scholar Rock, Dewpoint Therapeutics, Clementia Pharmaceuticals, Accent Therapeutics, Solid Biosciences, Centessa Pharmaceuticals, Kronos Bio, Chinook Therapeutics, Artiva Biotherapeutics, Akouos, Gritstone Oncology, aTyr Pharma, Kura Oncology, Kezar Life Sciences, Arcus Biosciences, Nurix Therapeutics, Syndax Pharmaceuticals, Cellares, Shattuck Labs, Neurogene, SAGE Therapeutics. Over time, Sarah Marriott has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sarah Marriott is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Investment Management, Android, Life Science, Biotech, Software, Healthcare, Biotechnology, Productivity Software, Health Diagnostics, Medical, Therapeutics, Media and Entertainment, Developer Platform, Pharmaceuticals may find it worthwhile to explore potential connections with Sarah Marriott, as their portfolio suggests a familiarity and interest in this area.

Understanding Sarah Marriott’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.